Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Publication of GT200600212ApublicationCriticalpatent/GT200600212A/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A UN NUEVO ANTICUERPO ANTI-MCP-1, QUE INCLUYE ÁCIDO NUCLEICOS AISLADOS QUE CODIFICAN POR LO MENOS UN ANTICUERPO ANTI-MCP-1, MCP-1, VECTORES, CÉLULAS HUÉSPED, ANIMALES O PLANTAS TRANSGÉNICAS, Y MÉTODOS PARA PREPARAR Y USAR A ESTOS, QUE INCLUYEN COMPOSICIONES, MÉTODOS Y DISPOSITIVOS TERAPÉUTICOS. T2006THE PRESENT INVENTION REFERS TO A NEW ANTIBODY ANTI-MCP-1, WHICH INCLUDES ISOLATED NUCLEIC ACID THAT CODIFY AT LEAST AN ANTIBODY ANTI-MCP-1, MCP-1, VECTORS, GUEST CELLS, ANIMALS OR TRANSGEN PLANTES AND PLANTES PREPARE AND USE THESE, WHICH INCLUDE COMPOSITIONS, METHODS AND THERAPEUTIC DEVICES. T2006
GT200600212A2005-05-192006-05-19
ANTI-MCP-1 ANTIBODIES, COMPOSITIONS, METHODS AND USES
GT200600212A
(en)